N-(7-Methyl-2,3-dihydro-1H-inden-4-yl)-4-methylpyrrolidin-2-imine Hydrochloride

ID: ALA3408294

Chembl Id: CHEMBL3408294

PubChem CID: 89964926

Max Phase: Preclinical

Molecular Formula: C15H21ClN2

Molecular Weight: 228.34

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(/N=C2/CC(C)CN2)c2c1CCC2.Cl

Standard InChI:  InChI=1S/C15H20N2.ClH/c1-10-8-15(16-9-10)17-14-7-6-11(2)12-4-3-5-13(12)14;/h6-7,10H,3-5,8-9H2,1-2H3,(H,16,17);1H

Standard InChI Key:  BBTPWUDIUFTVPM-UHFFFAOYSA-N

Associated Targets(Human)

ADRA2A Tclin Adrenergic receptor alpha-2 (812 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nisch Nischarin (241 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 228.34Molecular Weight (Monoisotopic): 228.1626AlogP: 3.33#Rotatable Bonds: 1
Polar Surface Area: 24.39Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.86CX LogP: 3.56CX LogD: 2.13
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.78Np Likeness Score: -0.10

References

1. Gasparik V, Greney H, Schann S, Feldman J, Fellmann L, Ehrhardt JD, Bousquet P..  (2015)  Synthesis and biological evaluation of 2-aryliminopyrrolidines as selective ligands for I1 imidazoline receptors: discovery of new sympatho-inhibitory hypotensive agents with potential beneficial effects in metabolic syndrome.,  58  (2): [PMID:25521963] [10.1021/jm501456p]

Source